AdaptHealth (AHCO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Apr, 2026Executive summary
Annual meeting scheduled for June 18, 2026, with voting on director elections, auditor ratification, and executive compensation (say-on-pay).
Proxy materials distributed electronically to enhance efficiency and sustainability.
Record date for voting is April 24, 2026, with 136,054,152 shares outstanding.
Voting matters and shareholder proposals
Shareholders will vote to elect nine directors for one-year terms, ratify KPMG LLP as auditor for 2026, and approve executive compensation in a non-binding advisory vote.
Board recommends voting in favor of all proposals.
Plurality voting for directors; majority of votes cast required for auditor ratification and say-on-pay.
No other business is expected at the meeting.
Board of directors and corporate governance
Board declassification completed; all directors now elected annually.
Nine director nominees, with a majority deemed independent under Nasdaq rules.
Board committees: Audit, Compensation, and Corporate Compliance & Governance, all with independent members.
Board leadership split between independent Chair and CEO.
Board and committees met five times in 2025; strong attendance.
Latest events from AdaptHealth
- Portfolio refocus and tech-driven growth in sleep and respiratory segments drive strong results.AHCO
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 revenue rose up to 15.9%, but a $144M goodwill impairment drove a net loss.AHCO
Q2 2026 - All proposals passed, directors elected, and no relevant questions were raised.AHCO
AGM 2026 - Major new capitated contract boosts growth, with margins set to improve through 2026.AHCO
Bank of America Global Healthcare Conference 2026 - Net revenue up 5.4% to $819.8M, but margin and net loss worsened amid higher costs.AHCO
Q1 2026 - Record operational gains and exclusive payer contracts drive growth and portfolio focus.AHCO
Leerink Global Healthcare Conference 2026 - Q2 net revenue rose 1.6% to $806M, net income up 39%, and free cash flow surged.AHCO
Q2 2024 - Q3 2024 returned to profitability with improved cash flow, but guidance was lowered.AHCO
Q3 2024 - 2024 results exceeded guidance, returning to profitability with strong cash flow and stable outlook.AHCO
Q4 2024